Deciphera Pharmaceuticals, Inc. (DCPH)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 15.77 |
| Open | 15.85 |
| Bid | 15.60 x 800 |
| Ask | 16.39 x 1100 |
| Day's Range | 15.77 - 16.43 |
| 52 Week Range | 6.51 - 37.99 |
| Volume | |
| Avg. Volume | 979,393 |
| Market Cap | 1.097B |
| Beta (5Y Monthly) | 1.10 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Deciphera Pharmaceuticals (NASDAQ:DCPH) adds US$249m to market cap in the past 7 days, though investors from three years ago are still down 53%
It is doubtless a positive to see that the Deciphera Pharmaceuticals, Inc. ( NASDAQ:DCPH ) share price has gained some...
- Zacks
Deciphera (DCPH) Loss Narrows in Q2, Qinlock Drive Revenues
Deciphera (DCPH) reports a narrower-than-expected loss in the second quarter of 2022 while revenues beat estimates. Shares rise.
- Zacks
Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q2 Loss, Tops Revenue Estimates
Deciphera Pharmaceuticals, Inc. (DCPH) delivered earnings and revenue surprises of 7.69% and 7.56%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2022 Yahoo. All rights reserved.
